Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Zaja-Milatovic S, Gupta RC, Aschner M, Milatovic D.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):124-31. doi: 10.1016/j.taap.2009.07.006. Epub 2009 Jul 14.

2.

Neuronal oxidative injury and dendritic damage induced by carbofuran: protection by memantine.

Gupta RC, Milatovic S, Dettbarn WD, Aschner M, Milatovic D.

Toxicol Appl Pharmacol. 2007 Mar;219(2-3):97-105. Epub 2006 Nov 1.

PMID:
17188316
3.

Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum.

Zaja-Milatovic S, Gupta RC, Aschner M, Montine TJ, Milatovic D.

Neurotoxicology. 2008 Jul;29(4):621-7. doi: 10.1016/j.neuro.2008.04.009. Epub 2008 Apr 29.

5.

Nitrone spin trapping compound N-tert-butyl-alpha-phenylnitrone prevents seizures induced by anticholinesterases.

Zivin M, Milatovic D, Dettbarn WD.

Brain Res. 1999 Dec 11;850(1-2):63-72.

PMID:
10629749
6.

Anticholinesterase toxicity and oxidative stress.

Milatovic D, Gupta RC, Aschner M.

ScientificWorldJournal. 2006 Feb 28;6:295-310. Review.

7.
8.

Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Milatovic D, Gupta RC, Yu Y, Zaja-Milatovic S, Aschner M.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):219-26. doi: 10.1016/j.taap.2011.06.001. Epub 2011 Jun 13.

9.

Carbofuran-induced oxidative stress in slow and fast skeletal muscles: prevention by memantine and atropine.

Milatovic D, Gupta RC, Dekundy A, Montine TJ, Dettbarn WD.

Toxicology. 2005 Mar 1;208(1):13-24.

PMID:
15664429
10.

N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole-induced convulsions and morphological changes in rat brain neurons.

Zaitsev AV, Kim KKh, Vasilev DS, Lukomskaya NY, Lavrentyeva VV, Tumanova NL, Zhuravin IA, Magazanik LG.

J Neurosci Res. 2015 Mar;93(3):454-65. doi: 10.1002/jnr.23500. Epub 2014 Oct 31.

PMID:
25359451
11.

Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity.

Gupta RC, Milatovic D, Dettbarn WD.

Arch Toxicol. 2002 Dec;76(12):715-26. Epub 2002 Oct 17.

PMID:
12451448
12.

Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury.

Li Y, Lein PJ, Liu C, Bruun DA, Giulivi C, Ford GD, Tewolde T, Ross-Inta C, Ford BD.

Toxicol Appl Pharmacol. 2012 Jul 15;262(2):194-204. doi: 10.1016/j.taap.2012.05.001. Epub 2012 May 11.

13.

Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-D-asparate-type glutamate receptors.

Butler TR, Self RL, Smith KJ, Sharrett-Field LJ, Berry JN, Littleton JM, Pauly JR, Mulholland PJ, Prendergast MA.

Neuroscience. 2010 Jan 20;165(2):525-34. doi: 10.1016/j.neuroscience.2009.10.018.

14.

Effects of curcumin and tannic acid on the aluminum- and lead-induced oxidative neurotoxicity and alterations in NMDA receptors.

Tüzmen MN, Yücel NC, Kalburcu T, Demiryas N.

Toxicol Mech Methods. 2015 Feb;25(2):120-7. doi: 10.3109/15376516.2014.997947. Epub 2015 Feb 24.

PMID:
25496357
15.

Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain.

Milatovic D, Gupta RC, Dettbarn WD.

Brain Res. 2002 Dec 13;957(2):330-7.

PMID:
12445975
16.

Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats.

Rao VL, Dogan A, Todd KG, Bowen KK, Dempsey RJ.

Brain Res. 2001 Aug 17;911(1):96-100.

PMID:
11489449
17.
18.

DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of beta-tubulin subtypes in the CNS of hens contributes to OPIDN.

Damodaran TV, Gupta RP, Attia MK, Abou-Donia MB.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):132-42. doi: 10.1016/j.taap.2009.07.035. Epub 2009 Aug 5.

PMID:
19664648
19.

In vitro galantamine-memantine co-application: mechanism of beneficial action.

Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.

Neuropharmacology. 2006 Dec;51(7-8):1181-91. Epub 2006 Sep 29.

PMID:
17011596
20.

Supplemental Content

Support Center